bodyguard, page-7

Quarterly Report for the Period Ended 30 September 2017

3.1 BodyGuardBodyGuard has taken several significant steps forward over this period with:

 As previously announced, the Company is partnering with an international manufacturer to produce high quality prototype KneeGuards to use with attracting potential partnering companies for the distribution of the BodyGuard product range. The tooling and knives have been completed and with the key components of the first Bodyguard product (KneeGuard) now being proven for different formulations.

 Discussions with one key potential partnering company with whom OBJ has been in liaison for several years has focused attention on the use of the “Popper” version of the BodyGuard and there is an intention to undertake clinical trials with this version in the next six months.

The trial using ibuprofen with the BodyGuard product is underway at Curtin University and is expected to take a further four months to complete.

The intention is to launch the first BodyGuard products during calendar 2018. There are several forms of BodyGuard and most of the past two years of development has been focused on the hydrogel formulation technology and the different active ingredients and getting the first KneeGuard version to a manufacturable standard. This has now been achieved which is most pleasing.

So Im curious to what these active ingredients will be & how many products we are talking about? This I assume does not require FDA approval as it's not Ibuprofen. Would be great to get more info soon!